🕵️ NUO Therapeutics, Inc. ($AURX)
SEC insider & ownership activity, last 12 months · CIK 1091596 · every row links its SEC filing
Over the last 12 months insiders sold $300K against $200K of open-market buying. Jorden David Emerson sold $300K in discretionary trades (Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $200K (1 lots) · 1 seller, $300K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jorden David Emerson | 0 | – | 1 | $300K | Nov 28, 2025 |
| Charles E. Sheedy | 1 | $200K | 0 | – | Jul 30, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Scott M. Pittman | 11.6% | 13D | May 29, 2026 | filing ↗ | |
| Jacobs Paul Anthony | 6.6% | 13G | Feb 12, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | May 29, 2026 | filing ↗ |
| New financial obligation (2.03) | May 29, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 29, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 21, 2026 | filing ↗ |
| New financial obligation (2.03) | Jan 21, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | Dec 16, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 7, 2025 | filing ↗ |
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 (5.08) | Oct 7, 2025 | filing ↗ |
| Other events (8.01) | Oct 7, 2025 | filing ↗ |